Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : Eli Lilly and Company Limited, Indianapolis

Femme et Homme Max 99 ans
Eli Lilly and Company Limited, Indianapolis MAJ Il y a 4 ans

A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients with Diabetic Kidney Disease due to Type 1 or Type 2 Diabetes Primary objective is to determine if LY2382770, administered monthly for 1 year is more effective than placebo at slowing the progression of diabetic kidney disease in patients treated with angiotensi...

Pays Aucun
Organes Aucun
Spécialités Aucune

Essai clos aux inclusions

Plus d'informations